- Home
- DTSQ vs INCR Comparison
DTSQ vs INCR Comparison
Compare DTSQ & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTSQ
- INCR
- Stock Information
- Founded
- DTSQ 2022
- INCR 1994
- Country
- DTSQ United States
- INCR Israel
- Employees
- DTSQ N/A
- INCR N/A
- Industry
- DTSQ
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- DTSQ
- INCR Health Care
- Exchange
- DTSQ NYSE
- INCR Nasdaq
- Market Cap
- DTSQ 91.7M
- INCR 84.5M
- IPO Year
- DTSQ 2024
- INCR N/A
- Fundamental
- Price
- DTSQ $10.39
- INCR $1.50
- Analyst Decision
- DTSQ
- INCR
- Analyst Count
- DTSQ 0
- INCR 0
- Target Price
- DTSQ N/A
- INCR N/A
- AVG Volume (30 Days)
- DTSQ 775.0
- INCR 25.4K
- Earning Date
- DTSQ 01-01-0001
- INCR 08-15-2025
- Dividend Yield
- DTSQ N/A
- INCR N/A
- EPS Growth
- DTSQ N/A
- INCR N/A
- EPS
- DTSQ 0.28
- INCR N/A
- Revenue
- DTSQ N/A
- INCR $65,575,323.00
- Revenue This Year
- DTSQ N/A
- INCR $69.54
- Revenue Next Year
- DTSQ N/A
- INCR $41.75
- P/E Ratio
- DTSQ $37.10
- INCR N/A
- Revenue Growth
- DTSQ N/A
- INCR N/A
- 52 Week Low
- DTSQ $9.96
- INCR $1.17
- 52 Week High
- DTSQ $10.47
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- DTSQ N/A
- INCR 46.56
- Support Level
- DTSQ N/A
- INCR $1.48
- Resistance Level
- DTSQ N/A
- INCR $1.64
- Average True Range (ATR)
- DTSQ 0.00
- INCR 0.05
- MACD
- DTSQ 0.00
- INCR 0.00
- Stochastic Oscillator
- DTSQ 0.00
- INCR 32.00
About DTSQ DT CLOUD STAR ACQUISITION CORP
DT Cloud Star Acquisition Corp is a blank check company.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.